A combined DNA vaccine provides protective immunity against mycobacterium bovis and brucella abortus in cattle

DNA and Cell Biology

Volumn 28, Issue 4, 2009, Pages 191-199

  Hu, Xi Dan ^a   Yu, Da Hai ^b   Chen, Su Ting ^b   Li, Shu Xia ^a   Cai, Hong ^b  

^a Xinjiang Academy of Animal Science   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BRUCELLA VACCINE; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERFERON GAMMA (1 39); INTERFERON GAMMA (1-39); PEPTIDE FRAGMENT; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; BOVINE TUBERCULOSIS; BRUCELLA ABORTUS; BRUCELLOSIS; CATTLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNIZATION; IMMUNOGENICITY; MALE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; LUNG; MOUSE; PATHOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS; BRUCELLA MELITENSIS BIOVAR ABORTUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

ANIMALS; BRUCELLA ABORTUS; BRUCELLOSIS, BOVINE; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON-GAMMA; LUNG; MALE; MICE; MYCOBACTERIUM BOVIS; PEPTIDE FRAGMENTS; TUBERCULOSIS VACCINES; TUBERCULOSIS, BOVINE; VACCINES, COMBINED; VACCINES, DNA;

EID: 64549157947     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0790     Document Type: Article

References (28)

1. Baek, K.M., Ko, S.Y., Lee, M., Lee, J.S., Kim, J.O., Ko, H.J., Lee, J.W., Lee, S.H., Cho, S.N., and Kang, C.Y. (2003). Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65. Vaccine 21, 3684-3689.
2. Baldi, P.C., Giambartolomei, G.H., Goldbaum, F.A., Abdon, L.F., Velikovsky, C.A., Kittelberger, R., and Fossati, C.A. (1996). Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Clin Diagn Lab Immunol 3, 472-476.
3. Brandt, L., Feino Cunha, J., Weinreich Olsen, A., Chilima, B., Hirsch, P., Appelberg, R., and Andersen, P. (2002). Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70, 672-678.
4. Buddle, B.M. (2001). Vaccination of cattle against Mycobacterium bovis. Tuberculosis (Edinb) 81, 125-132.
5. Cai, H., Tian, X., Hu, X.D., Li, S.X., Yu, D.H., and Zhu, Y.X. (2005). Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection. Vaccine 23, 3887-3895.
6. Cai, H., Yu, D.H., Hu, X.D., Li, S.X., and Zhu, Y.X. (2006). A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge. DNA Cell Biol 25, 438-447.
7. Coler, R.N., Campos-Neto, A., Ovendale, P., Day, F.H., Fling, S.P., Zhu, L., Serbina, N., Flynn, J.L., Reed, S.G., and Alderson, M.R. (2001). Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis. J Immunol 166, 6227-6235.
8. Cooper, A.M., Dalton, D.K., Stewart, T.A., Griffin, J.P., Russell, D.G., and Orme, I.M. (1993). Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178, 2243-2247.
9. Corbel, M.J. (1997). Brucellosis: an overview. Emerg Infect Dis 3, 213-221.
10. Dames, S., Tonnerre, C., Saint, S., and Jones, S.R. (2005). Clinical problem-solving. Don't know much about history. N Engl J Med 352, 2338-2342.
11. Donnelly, J.J., Wahren, B., and Liu, M.A. (2005). DNA vaccines: progress and challenges. J Immunol 175, 633-639.
12. Flynn, J.L., and Chan, J. (2001). Immunology of tuberculosis. Annu Rev Immunol 19, 93-129.
13. Gilbert, S.C., Moorthy, V.S., Andrews, L., Pathan, A.A., McConkey, S.J., Vuola, J.M., Keating, S.M., Berthoud, T., Webster, D., McShane, H., and Hill, A.V. (2006). Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 24, 4554-4561.
14. Jamal, S.M., Afzal, M., and Ahmed, S. (2003). The immune response of guinea pigs and buffalo calves to the locally prepared Brucella abortus strain 19 vaccine. Rev Sci Tech 22, 893-897.
15. Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S.E., Fondaneche, M.C., Dupuis, S., Doffinger, R., Altare, F., Girdlestone, J., Emile, J.F., Ducoulombier, H., Edgar, D., Clarke, J., Oxelius, V.A., Brai, M., Novelli, V., Heyne, K., Fischer, A., Holland, S.M., Kumararatne, D.S., Schreiber, R.D., and Casanova, J.L. (1999). A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 21, 370-378.
16. McShane, H., Pathan, A.A., Sander, C.R., Keating, S.M., Gilbert, S.C., Huygen, K., Fletcher, H.A., and Hill, A.V. (2004). Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10, 1240-1244.
17. Mogues, T., Goodrich, M.E., Ryan, L., Lacourse, R., and North, R.J. (2001). The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 193, 271-280.
18. Moore, A.C., and Hill, A.V. (2004). Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunol Rev 199, 126-143.
19. Moriyon, I., Grillo, M.J., Monreal, D., Gonzalez, D., Marin, C., Lopez-Goni, I., Mainar-Jaime, R.C., Moreno, E., and Blasco, J.M. (2004). Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35, 1-38.
20. Olsen, S.C., Evans, D., Hennager, S.G., Cheville, N.F., and Stevens, M.G. (1996). Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51. J Vet Diagn Invest 8, 451-454.
21. Pappas, G., Akritidis, N., Bosilkovski, M., and Tsianos, E. (2005). Brucellosis. N Engl J Med 352, 2325-2336.
22. Poester, F.P., Goncalves, V.S., Paixao, T.A., Santos, R.L., Olsen, S.C., Schurig, G.G., and Lage, A.P. (2006). Efficacy of strain RB51 vaccine in heifers against experimental brucellosis. Vaccine 24, 5327-5334.
23. Schurig, G.G., Sriranganathan, N., and Corbel, M.J. (2002). Brucellosis vaccines: past, present and future. Vet Microbiol 90, 479-496.
24. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Dwarki, V.J., Gromkowski, S.H., Deck, R.R., Dewitt, C.M., Friedman, A., et al. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
25. Wyckoff, J.H., 3rd, Howland, J.L., Scott, C.M., Smith, R.A., and Confer, A.W. (2005). Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle. Vet Microbiol 111, 77-87.
26. Yang, X., Walters, N., Robison, A., Trunkle, T., and Pascual, D.W. (2007). Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization. Vaccine 25, 2261-2268.
27. Yu, D.H., Hu, X.D., and Cai, H. (2007a). A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses. DNA Cell Biol 26, 435-443.
28. Yu, D.H., Li, M., Hu, X.D., and Cai, H. (2007b). A combined DNA vaccine enhances protective immunity against Myco- bacterium tuberculosis and Brucella abortus in the presence of an IL-12 expression vector. Vaccine 25, 6744-6754.